(1) To show that extracellular matrix deposition in 3-dimensional culture of human septal chondrocytes cultured in a rotary bioreactor is comparable to the deposition achieved under static culture conditions. (2) To demonstrate that the biomechanical properties of human septal chondrocytes cultured in a bioreactor are enhanced with time and are analogous to beads cultured under static culture.
T he repair of cartilaginous defects created by trauma, tumor resection, and congenital deformities requires analogous reconstructive material to obtain optimal results. Components used for grafting include autologous, allogenic, and synthetic structures. The use of synthetic grafts may be complicated by infection and extrusion, whereas allogenic grafts carry the risk of immune rejection and disease transmission. [1] [2] [3] [4] Therefore, autologous grafts are favored. Potential autologous cartilage donor sites include the nasal septum, auricle, and rib. Nasal septal cartilage offers significant advantages over these other cartilage donor sites because of its superior structural properties, ease of harvest, and minimal donor site morbidity. However, the use of nasal septal cartilage is limited by the finite amount of tissue available and potentially suboptimal geometric structure for repair of some defects. Tissue engineering of autologous neocartilage, therefore, offers the potential to produce large quantities of autologous cartilage from a small donor specimen and affords the ability to create grafts in defined shapes and sizes.
Nasal septal cartilage engineering involves several key steps. Cartilage is harvested from a donor, and chondrocytes are isolated by digesting the extracellular matrix (ECM). Chrondrocytes are then proliferated in monolayer culture, which causes the chondrocytes to undergo a shift toward a fibroblastic phenotype in a process called dedifferentiation. Dedifferentiation is necessary to achieve expansion of cell number in monolayer. This is accompanied by a change from the production of type II collagen (characteristic of native chondrocytes) to type I collagen (characteristic of fibroblasts). 5, 6 If a dedifferentiated chondrocyte regains its native phenotype, it is referred to as redifferentiated. The cells are then cultured in a 3-dimensional (3D) configuration that induces redifferentiation and restores the chondrocyte phenotype to enable production of functional cartilaginous ECM. [7] [8] [9] The redifferentiated cells are then incubated to form neocartilage constructs that can eventually be used for clinical application. Multiple factors influence chondrocyte redifferentiation, including media composition, growth factors, cell seeding density, 3D scaffold properties, and physical stimulation. In turn, these factors affect the ability of chondrocytes to produce functional cartilaginous matrix and thereby form clinically useful cartilage constructs.
Mechanical stimulation has been shown to favorably influence cartilage formation and, therefore, is an important factor to take into account during the development of tissueengineered cartilage. 10 To address this issue, bioreactors have been created that allow for the control of mechanical stimuli and fluid flow. Studies using tissue-engineered articular cartilage have demonstrated improved histological and biochemical properties after culture in a bioreactor (BR) compared with static conditions. [11] [12] [13] [14] The application of BRs to septal tissue engineering has been limited. Moreover, the development of tissue-engineered nasal septal constructs that possess the biomechanical and biological properties of native tissue has not yet been achieved. The goal of this study was to determine whether 3D culture of human nasal septal chondrocytes in a rotary BR is comparable to static culture. In addition, the biomechanical properties of alginate-embedded human septal chondrocytes cultured in a BR and static culture are assessed.
Methods

Chondrocyte Isolation and Expansion
The study used remnant human septal specimens removed during routine surgery at the University of California, San Diego Medical Center or San Diego Veterans Affairs Medical Center. Institutional review board approval was obtained at both institutions. The cartilage specimens were dissected free of perichondrium and diced into pieces (1 mm 3 ). The fragments were digested as reported previously. 15 Suspensions of digested cartilage were filtered (70 mm) and then washed and centrifuged. Cells were resuspended in cell culture medium (DMEM [low glucose], 2% pooled human AB serum [Gemini Bioproducts, Woodland, California], 25 mg/mL ascorbate, 0.4 mmol/L l-proline, 2 mmol/L l-glutamine, 0.1 mmol/L nonessential amino acids, 10 mmol/L HEPES buffer, 100 U/mL penicillin G, 100 mg/ mL streptomycin sulfate, 0.25 mg/mL amphotericin B). The number of chondrocytes was determined by hemocytometer counting after trypan blue exclusion.
For each patient, isolated chondrocytes were seeded at low density (5000 cells per cm 2 surface area) into T-175 flasks. Monolayer cultures were incubated in a humidified atmosphere at 37°C with 5% carbon dioxide/air. Culture medium was supplemented with 1 ng/mL transforming growth factor b-1, 5 ng/mL fibroblast growth factor-2, and 10 ng/mL platelet-derived growth factor-bb and changed every 2 days. Chondrocytes were grown until confluency (6-8 days) .
Culture in Alginate
The expanded cells were released from monolayer and resuspended in alginate as described previously. 15 After washing with 0.9% saline, 100 beads were transferred to a 250-mL Nalgene PETG square media bottle and 100 beads were transferred to a 50-mL disposable rotary cell culture vessel (Sythecon, Inc, Houston, Texas). Fifty milliliters of alginate culture medium (DMEM/F-12, 25 mg/mL ascorbate, 0.4 mM L-proline, 2 mM L-glutamine, 0.1 mM nonessential amino acids, 10 mM L HEPES buffer, 100 U/mL penicillin G, 100 mg/mL streptomycin sulfate, 0.25 mg/mL amphotericin B) supplemented with 2% human AB serum, 100 ng/mL bone morphogenic protein-14, and 200 ng/mL insulin growth factor-1 was placed in the media bottle and rotary culture vessel and changed every 2 to 3 days. Day zero beads were set aside for each patient to assess histological, biochemical, and biomechanical properties.
Release from Alginate Culture
Culture of alginate beads was terminated at 10 and 21 days. Alginate beads were either subjected to mechanical testing or depolymerized using a solution of 55 mM sodium citrate and 0.15 mM NaCl. Centrifugation at 750g for 5 minutes was then undertaken to separate the supernatant from the pellet consisting of recovered chondrocytes with associated ECM. The pellets being used for the biochemical assays were digested either with proteinase K (PK) in phosphatebuffered EDTA or pepsin overnight.
Quantitative Assay for Cellularity
Cellularity of the terminated and day zero cultures was tested using the PicoGreen DNA content determination assay as described in a previous report. 15, 16 DNA content was normalized per bead.
Quantitative Assay for Glycosaminoglycan
The glycosaminoglycan (GAG) content was determined, as reported previously, using portions of the PK digests and the dimethyl-methylene blue reaction. 15 GAG content was then normalized per bead and DNA content. 17 
Quantitative Assays for Type I and II Collagen
The amount of type I and type II collagen in PK digests was quantified by enzyme-linked immunosorbent assay (ELISA) using human type I and native type II collagen kits (Chrondrex Inc, Redmond, Washington). 18 Collagen was digested by sequential incubation with 5000 U/mL bovine hyaluronidase (Sigma-Aldrich, St Louis, Missouri) at 4°C overnight, followed by 2 incubations with 10 mg/mL pepsin (Sigma-Aldrich) dissolved in 0.05 M acetic acid at 4°C overnight. Finally, the samples were incubated with 1 mg/ mL pancreatic elastase (Sigma-Aldrich) at 4°C for 16 hours. Separate type I and type II collagen ELISAs were performed following the manufacturer's instructions. The optical density was read at 490 nm using a spectrophotometric plate reader. Collagen values were then normalized per bead and DNA content.
Histology
Beads were analyzed by histochemistry to localize GAG and by hematoxylin and eosin (H&E) staining. After depolymerization of the alginate beads, the cells were pelleted, rinsed, and resuspended in phosphate-buffered saline (PBS). They were placed on poly-L-lysine coated slides (Polysciences Inc, Warrington, Pennsylvania) and allowed to dry overnight. Staining with H&E was performed as previously described. 19 For histochemical localization of GAG, slides from each sample group were stained with 0.1% Alcian blue in buffer (0.4 M MgCl 2 , 0.025 M Na acetate, 2.5% glutaraldehyde, pH 5.6) overnight and destained with 3% acetic acid until clear. 20 Samples were then observed using light microscopy.
Immunohistochemistry
Immunohistochemistry was performed with the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, California), a peroxidase-based detection system. The slides were prepared as described above. After rinsing in ABC buffer, the samples were blocked with 2.5% normal horse serum for 20 minutes. The samples were then probed with 1 of 3 antibodies: anti-collagen type I (Sigma, St Louis, Missouri) at a dilution of 1:2000, anti-collagen type II (Chrondrex Inc, Redmond, Washington) at a dilution of 1:10,000, or a mouse nonspecific immunoglobulin G used at 1 mg/mL as a negative control. Sections were counterstained with methyl green nuclear stain (Vector Laboratories, Burlingame, California). Samples were then documented by photomicroscopy.
Biomechanical Testing
Alginate beads at day zero and day 21 of culture were collected for each sample and condition. The thickness of each bead was measured twice using a contact-sensing micrometer. Alginate beads were transferred to an unconfined test chamber filled with PBS with calcium and magnesium solution at 22°C and attached to a mechanical spectrometer (DynaStat, IMASS, Accord, Massachusetts). Automated electromechanical testing and data acquisition were implemented by interfacing a computer-controlled function generator (HP33120A, Hewlett-Packard, Palo Alto, California) to the mechanical spectrometer and by interfacing the load and displacement signals from the spectrometer as well as the streaming potential signal from the amplifier to a multifunction 16-bit I/O board (NB-MIO-16XH-42, National Instruments, Austin, Texas). A 50-g load cell with attached 0.5-in plunger was used. The test sequence consisted of applying 0% to 25% ramp compression over 60 seconds to the sample and allowing the resultant load to relax to equilibrium for 300 seconds. This was followed by application of a series of oscillatory displacements decreasing in amplitude (relative to the compressed thickness) from 3% at frequencies of 0.01, 0.1, and 1 Hz while the load was measured.
The compressive properties of the alginate bead samples were estimated from the acquired data assuming tissue homogeneity. The Young's modulus (E) was determined from the static equilibrium data.
Statistical Analysis
Analysis was performed using Systat 10.2 (Systat Software, Chicago, Illinois). Means and standard deviation (SD) are presented. Differences in DNA content per bead and GAG per bead were assessed using repeated-measures analysis of variance (ANOVA) with 2 within-subject factors, condition and time, to determine the fixed effect of condition and time. If the ANOVA identified an overall significant effect, post hoc Tukey's HSD tests were used to identify significant differences between time points. A paired t test was used to analyze the difference in type II collagen content and compression modulus between the static and BR conditions. Linear regression analysis was used to analyze the relationship between E and GAG and type II collagen content per bead as well as between bead diameter and GAG and type II collagen content. A difference was considered significant when P .05.
Results
Alginate beads gradually increased in size from day 0 until termination of culture at day 21 (2.2 6 0.04 and 2.64 6 0.33 mm, respectively). Biochemical testing demonstrated no difference in DNA content per alginate bead between the static and BR conditions (P = .476; data not shown). An initial decrease in DNA content per alginate bead from day 0 to day 10 of culture was demonstrated with 0.861 6 0.477 mg DNA per bead at day zero, 0.606 6 0.275 mg DNA per bead at day 10 in static culture, and 0.573 6 0.362 mg DNA per bead at day 10 in the BR. There was a significant increase in proliferation reflected by DNA content per bead from day 10 to day 21 of culture (0.747 6 0.170 mg DNA per bead in static culture and 0.890 6 0.402 mg DNA per bead in the BR; P \ .01). GAG accumulation, calculated as micrograms of GAG per alginate bead, did not differ significantly between static culture and the BR (P = .286). However, GAG content tended to increase from day 0 to 10 (P = .054) and there was a significant increase from day 10 to 21 (P = .001; Figure 1 ). GAG content at day 0 was 1.79 6 2.60 mg GAG per bead, which increased to 6.39 6 2.83 mg GAG per bead at day 10 in static culture and 6.58 6 3.65 mg GAG per bead at day 10 in the BR. GAG accumulation further increased to 37.62 6 14.03 mg GAG per bead at day 21 in static culture and 46.60 6 27.04 mg GAG per bead at day 21 in the BR. Type II collagen content in day zero beads was below the limit of detection for the assay. The day 21 beads showed a robust accumulation of type II collagen that did not significantly differ between the static and BR culture conditions (0.40 6 0.27 and 0.32 6 0.32 mg type II collagen per bead, respectively; P = .491; data not shown). Type I collagen content was below the limit of detection for the assay (0.08 mg/mL) in day 0 and day 21 beads for both conditions (data not shown).
Histological examination of the alginate beads confirmed the biochemical findings above. H&E staining of the alginate beads demonstrated increasing amounts of ECM surrounding each cell with increasing culture time. Alcian blue staining demonstrated robust staining in day 21 beads, indicating the presence of sulfated GAGs (Figure 2) . Immunohistochemical staining confirmed the absence of type I collagen in the alginate beads. Both day 10 and 21 beads demonstrated strong staining for type II collagen (Figure 3) . Overall, staining did not differ between the static and BR culture conditions. Compression testing of the alginate beads at day 0 and day 21 of culture showed that beads possessed significantly increased stiffness after 21 days of culture compared with day 0 beads (E = 1.69 6 0.44 and 2.43 6 0.61 mN/mm, respectively; P = .018). There was no difference in measured stiffness between static and BR conditions.
Linear regression demonstrated a significant correlation between GAG content per bead and bead stiffness ( Figure  4a ; P = .001). Additionally, bead stiffness significantly varied with type II collagen content per bead (Figure 4b ; P = .008). Bead diameter also significantly differed with both GAG and type II collagen content per bead (Figure 4 , c and d; P \ .0001).
Discussion
Human septal chondrocytes cultured in alginate beads exhibit significant GAG and type II collagen accumulation after 21 days of culture in both static and bioreactor conditions. This increase in matrix deposition is reflected in the enhanced compressive properties of 21 day beads. In addition, histological examination of the alginate beads confirms the robust accrual of both type II collagen and GAG. The content of GAG and type II collagen positively correlated with both alginate bead diameter and the Young's modulus. As the amount of collagen and GAG increased in a bead, the bead grew in size. In addition, the added ECM enhanced the compressive properties of the alginate beads.
Bioreactor systems provide mechanical stimulation during cell culture. This has been shown to favorably influence cartilage formation in vivo. 10 The chondrogenic effect of bioreactors on cultured articular chondrocytes has been well established. Sheehy and colleagues 14 studied the effect of dynamic rotational culture on porcine chondrocyte constructs. They found that rotation significantly increased GAG and collagen production in constructs compared with static culture. Freed and colleagues 21 Figure 1 . Quantity of GAG per alginate bead measured at day 0, 10, and 21 in static and BR culture conditions. GAG accumulation did not vary between the culture conditions. However, there was a tendency toward increased GAG content from day 0 to 10 and a significant increase in GAG from day 10 to 21 (P = .001). Error bars depict standard deviation. cultured them in a rotating bioreactor for 40 days. The resultant constructs accumulated GAG and type II collagen, suggesting the promising effect of rotating bioreactors on chondrogenesis. Similarly, Vunjak-Novakovic and colleagues 22 cultured bovine articular chondrocytes for 6 weeks on fibrous polyglycolic acid scaffolds in static flasks, mixed flasks, and rotating vessels. They found that static culture and mixed flasks produced constructs with poor mechanical properties. However, the constructs cultured in rotating vessels exhibited robust ECM with the highest percentage of GAG and collagen, in addition to superior mechanical properties. Pound and colleagues 23 cultured human articular chondrocytes encapsulated in alginate/chitosan microcapsules. The chondrocytes were cultured in a rotating bioreactor, perfused bioreactor, and static conditions for 28 days. Chondrocytes cultured in the rotating bioreactor showed histological characteristics similar to native cartilage, whereas those cultured in the other conditions were less organized. In addition, chondrocytes cultured in the rotating bioreactor demonstrated increased DNA and protein content compared with perfused or static culture. These studies suggest that the use of bioreactor systems for the culture of articular cartilage constructs may promote chondrogenesis and enhance tissue maturation. The application of bioreactors in nasal septal tissue engineering has been limited. The use of bioreactors for the culture of alginate-embedded chondrocytes has not been previously studied. Gorti and colleagues 24 observed a more mechanically robust construct with handling when human septal chondrocytes were cultured in a slowly turning lateral vessel bioreactor for 6 weeks compared with constructs cultured in a spinner flask for 14 days; however, no tests were performed to confirm the biomechanical integrity. Rotter and colleagues 25 cultured constructs on resorbable polymer fleece in a perfusion culture vessel for up to 14 days. They reported that all the constructs maintained their original size and shape after 10 days in perfusion culture and the integrity of the polymer scaffolds was maintained. Histological evaluation of the constructs confirmed the presence of ECM and collagen; however, no quantitative measurements were obtained. More recently, Bichara and colleagues 26 seeded human septal chondrocytes onto nondegradable porous poly(vinyl alcohol) hydrogel to create biosynthetic constructs. These were either directly implanted into nude mice or first cultured in a spinner flask bioreactor system for 10 days and then implanted into the mice. The constructs were then compared after 6 weeks of in vivo implantation. The investigators found that the constructs initially cultured in the bioreactor had higher levels of DNA, GAG, and hydroxyproline (a measure of collagen). In addition, these constructs showed a 22% increase in compressive strength. Overall, the use of bioreactors in tissue-engineered articular and septal cartilage has been promising. However, prior to this study, the application of a rotating bioreactor for the culture of human nasal septal chondrocytes embedded in alginate had not been performed.
Although the results of this study are encouraging, additional work is needed to ultimately produce clinically useful cartilage constructs. While we show that culture in a rotating bioreactor produces comparable ECM and type II collagen production in alginate beads, no significant difference exists between the 2 culture systems. However, this study specifically focused on the alginate bead stage of culture and did not examine the effects of bioreactor culture at the construct stage. Prior studies using articular chondrocytes focused on bioreactor culture of constructs. 14, [21] [22] The evaluation of the effect of bioreactor culture on nasal septal construct maturation is planned for the future.
In this study, we successfully showed that human septal chondrocytes cultured in alginate beads exhibit significant matrix deposition and improved biomechanical properties after 21 days. Type II collagen and GAG accumulation significantly correlated with bead diameter and compressive properties. Enhanced matrix deposition during bead culture is expected to lead to formation of neocartilage that is comparable to native tissue. Additionally, GAG and type II collagen production in alginate beads cultured in a bioreactor is comparable to static culture. This is the first report describing biomechanical testing of chondrocytes embedded in alginate beads.
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